TuisTORNTPHARM • NSE
add
Torrent Pharmaceuticals Ltd
Vorige sluiting
₹2 953,70
Dagwisseling
₹2 945,65 - ₹3 005,00
Jaarwisseling
₹1 772,05 - ₹3 005,00
Markkapitalisasie
1,00 bn INR
Gemiddelde volume
231,56 k
P/V-verhouding
60,57
Dividend-opbrengs
0,94%
Primêre beurs
NSE
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (INR) | Mrt. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 27,45 mjd | 10,18% |
Bedryfskoste | 13,73 mjd | 9,78% |
Netto inkomste | 4,49 mjd | 51,70% |
Netto winsgrens | 16,37 | 37,68% |
Wins per aandeel | 13,27 | 56,49% |
EBITDA | 8,80 mjd | 25,48% |
Effektiewe belastingkoers | 28,80% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (INR) | Mrt. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 10,04 mjd | 38,91% |
Totale bates | 150,61 mjd | 0,32% |
Totale aanspreeklikheid | 82,04 mjd | -6,91% |
Totale ekwiteit | 68,56 mjd | — |
Uitstaande aandele | 338,45 m | — |
Prys om te bespreek | 14,58 | — |
Opbrengs op bates | — | — |
Opbrengs op kapitaal | 15,67% | — |
Kontantvloei
Netto kontantverandering
| (INR) | Mrt. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 4,49 mjd | 51,70% |
Kontant van bedrywe | — | — |
Kontant van beleggings | — | — |
Kontant van finansiering | — | — |
Netto kontantverandering | — | — |
Beskikbare kontantvloei | — | — |
Meer oor
Torrent Pharmaceuticals Ltd is an Indian multinational pharmaceutical company, part of the Torrent Group and headquartered in Ahmedabad. It was promoted by U. N. Mehta, initially as Trinity Laboratories Ltd, and was later renamed Torrent Pharmaceuticals Ltd.
Torrent Pharmaceuticals operates in more than 40 countries with over 2,000 product registrations globally. Torrent Pharma is active in the therapeutic areas of cardiovascular, central nervous system, gastro-intestinal, diabetology, anti-infective and pain management segments. It also has a presence in therapeutic segments of nephrology, oncology, gynecology and pediatrics. Wikipedia
Gestig
1959
Hoofkwartier
Webwerf
Werknemers
15 718
